A New Biomarkers Feature Pattern Consisting of TNF-α, IL-10, and IL-8 for Blood Stasis Syndrome with Myocardial Ischemia

Table 1

Changes of heart function evaluated by echocardiography (Mean ± SEM).

	Control (𝑁=10)	Model (𝑁=15)	𝑃 value
LVEDd (cm)	3.208±0.124^∗∗	3.895±0.076	0.000
LVEDs (cm)	2.041±0.043^∗∗	2.657±0.072	0.000
ESV (mL)	8.559±0.940^∗∗	16.115±1.217	0.003
EDV (mL)	22.542±2.117^∗∗	36.371±1.628	0.000
IVSDs (cm)	1.185±0.199^∗∗	0.833±0.032	0.004
IVSDd (cm)	0.692±0.029^∗	0.592±0.020	0.024
LVAWTs (cm)
Mitral valve level	1.029±0.055	1.004±0.027	0.665
Papillary muscles level	1.153±0.032^∗∗	0.849±0.044	0.001
Apex level	1.145±0.045^∗∗	0.623±0.044	0.000
LVAWTd (cm)
Mitral valve level	0.728±0.025	0.739±0.017	0.754
Papillary muscles level	0.794±0.034^∗	0.648±0.027	0.012
Apex level	0.808±0.040^∗∗	0.546±0.032	0.000
Wall thickening (%)
Mitral valve level	41.748±6.016	36.317±2.498	0.350
Papillary muscles level	47.325±7.038	30.136±3.268	0.023
Apex level	42.564±3.194^∗∗	12.072±1.887	0.000
FS (%)	35.818±1.752	30.835±2.780	0.372
EF (%)	61.770±2.067	56.299±2.020	0.189

Model versus Control group, *𝑃<0.05; **𝑃<0.01.
LVEDd: left ventricular end-diastolic dimension; LVEDs: left ventricular end-systolic dimension; ESV: end-systolic volume; EDV: end-diastolic volume; IVSDs: interventricular end-systolic septal depth; IVSDd: interventricular end-diastolic septal depth; LVAWTs: left ventricular end systolic anterior wall thickness; LVAWTd: left ventricular end diastolic anterior wall thickness; FS: fractional shortening; EF: ejection fraction.